THE EFFECTIVENESS OF HEPATOPROTECTORS IN THE COMPLEX TREATMENT OF CHRONIC PANCREATITIS AND TYPE 2 DIABETES

Аннотация:

Currently, the prevalence of diabetes and chronic pancreatitis is the highest among the world's population, especially among the elderly population (≥65 years old) compared to other diseases.  In addition, the prevalence of these diseases among the population is much younger compared to the age groups, which worries many health workers and government leaders.  Many scientists have observed that type 2 diabetes has the highest prevalence of any age group, and this number is projected to increase >4.5-fold between 2005 and 2050.  Among these diseases, the risk of developing acute and chronic diseases such as kidney disease, blindness, stroke, and coronary artery disease is high, causing long-term complications, reduced quality of life, high health care costs, and major public health problems.  is releasing.  That is why the development of comprehensive treatment and rehabilitation measures for these diseases is one of the main tasks facing the healthcare system.